Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06593093
Title field or adapter rule
{'original_value': 'A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-29T01:00:17.573888+00:00
Published At
2026-10-28T00:00:00+00:00
Record Updated At
2026-10-28
Results Posted At
2026-10-28
Source Retrieved At
2026-10-29T01:00:16.864611+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Opioid Use Disorder", "Opioid Overdose"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06593093"
protocolSection.identificationModule.officialTitle
"A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}

Study condition terms

  • Opioid Use Disorder (protocolSection.conditionsModule.conditions)
  • Opioid Overdose (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['phase 1 (only 1 arm)'], 'description': 'a bundled intervention, including peer support, buprenorphine (ranging from 4mg-24mg, oral, daily, or sublocade), physician care, telehealth, and community-based addiction programs.\n\nParticipants are enrolled to the experimental (bundled intervention) group. Bundled intervention components include scheduled peer support contacts, buprenorphine treatment with addiction physicians using telehealth, and linkage to definitive addiction treatment programs, up to 3 months after Emergency Department (ED)/hospital discharge. Participants complete baseline surveys on the day of informed consent. Participants are sent survey links to their cell phones and emails to complete self-report questionnaires via Qualtrics at 1- and 3-month follow-up assessments. Participants are reminded via text messages and/or emails to complete the survey twice per day 5 days prior to their follow-up assessments. Peers assist the participants to enter a definitive addiction treatment, including buprenorphine clinic.', 'name': 'a bundled intervention, including peer support specialist, buprenorphine, physician care, and telehealth', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • a bundled intervention, including peer support specialist, buprenorphine, physician care, and telehealth (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.